UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Use cases for Economic vs Market Index show when to rely on each signal, aiding risk assessment, timing, and portfolio adjustments.
28,511 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
The AI rally cooled, but the opportunity remains. This guide shares three AI stocks investors should load up on and a...
A major fund’s exit from Ocular Therapeutix raises questions about timing, liquidity, and sector signals. This articl...
An insider at Rackspace Technology recently disclosed a significant stock sale. This article explains what that means...
A 34% year-to-date drop has investors wondering if Zscaler can stage a comeback. This deep dive breaks down the catal...
NuScale Power stock has been under pressure as investors digest macro concerns and regulatory headwinds. This guide b...
When a chief financial officer sells a sizable chunk of stock, it draws attention. This article breaks down the impli...
Two NASA contract wins have put Intuitive Machines on investors’ radar, but do they move the needle for long-term ret...
AceableAgent teamed with Tom Ferry to unveil Fast Track, a compact coaching program designed to help new agents trans...
Rocket Lab has unveiled a bold $8 billion move by announcing a plan to acquire Iridium. This article breaks down what...
Biotech giants 2026 could offer a compelling mix of growth and stability for investors. This article dives into two p...
This comprehensive guide explains what frequent intraday trading is, who it suits, and how to manage risk with real-w...